Skip to search.
 TSX Up1.03% TSX Ventures 0.00%

Orexigen Therapeutics, Inc. (OREX)

-NMS

6.11 Up 0.09(1.50%) 4:00PM EDT

Add to Portfolio
Cash FlowGet Cash Flow for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period Ending2012-12-302011-12-302010-12-30
Net Income (90,094) (28,058) (51,915)
Operating Activities, Cash Flows Provided By or Used In
Depreciation813  1,504  1,793  
Adjustments To Net Income7,612  6,611  8,314  
Changes In Accounts Receivables -   -   -  
Changes In Liabilities13,878  (10,491)48,606  
Changes In Inventories -   -   -  
Changes In Other Operating Activities(551)1,231  (1,034)
Total Cash Flow From Operating Activities (68,342) (29,203) 5,764  
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures -   -  (45)
Investments(13,710)20,733  (13,967)
Other Cash flows from Investing Activities365  339  409  
Total Cash Flows From Investing Activities (13,345) 21,072   (13,603)
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid -   -   -  
Sale Purchase of Stock58,270  87,370  1,491  
Net Borrowings -  (2,416)(6,384)
Other Cash Flows from Financing Activities -   -   -  
Total Cash Flows From Financing Activities 58,270   84,954   (4,893)
Effect Of Exchange Rate Changes -   -   -  
Change In Cash and Cash Equivalents (23,417) 76,823   (12,732)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.